IL-10 nanoparticle capsules as therapeutic strategies can modulate the release of IL-6, IL-12p40, suppressor of cytokine signaling 1 (SOCS1), and SOCS3 by mitigating the inflammatory response against Chlamydia infection in macrophages (9). This evidence concerns the gene SOCS1 and chlamydia infectious disease.